(Q50134834)

25 February 2018

title

The delayed effects of DTG and MK-801 on latent inhibition in a conditioned taste-aversion paradigm. (English)

1 reference

25 February 2018

conditioned taste aversion

main subject

1 reference

S M Turgeon

1

1 reference

25 February 2018

E A Auerbach

2

1 reference

25 February 2018

M K Duncan-Smith

3

1 reference

25 February 2018

J R George

4

1 reference

25 February 2018

W W Graves

5

1 reference

25 February 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

25 February 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

25 February 2018

volume

66

1 reference

25 February 2018

issue

3

1 reference

25 February 2018

page(s)

533-539

1 reference

25 February 2018

Phencyclidine-induced psychosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Observations on the psychotomimetic effects of Sernyl.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

DTG-induced circling behaviour in rats may involve the interaction between sigma sites and nigro-striatal dopaminergic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

The behavior of APO-SUS rats in animal models with construct validity for schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Delayed regional metabolic actions of phencyclidine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

An increase in NMDA-sensitive [3H]glutamate and [3H]kainate binding in hippocampus 24 hours after PCP.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

MK801 induces late regional increases in NMDA and kainate receptor binding in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

BMY 14802, a sigma receptor ligand for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Release of [3H]dopamine from guinea pig striatal slices is modulated by sigma1 receptor agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI)

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

The involvement of sigma receptors in the choice reaction performance deficits induced by phencyclidine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

In vivo functional interaction between phencyclidine binding sites and sigma receptors to produce head-weaving behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Novel antipsychotic drugs share high affinity for sigma receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Latent inhibition in humans: data, theory, and implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

A rat model of phencyclidine psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced delayed cognitive dysfunction in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Increases in rat striatal extracellular dopamine and vacuous chewing produced by two sigma receptor ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Sigma receptors in schizophrenic cerebral cortices

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Selective sigma receptor agonist and antagonist affect dopamine neuronal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotypes behavior and ataxia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Latent inhibition in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Schizophrenia and glutamatergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

The delayed effects of phencyclidine (PCP) disrupt latent inhibition in a conditioned taste aversion paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

The delayed effects of phencyclidine enhance amphetamine-induced behavior and striatal C-Fos expression in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

A comparison of (-)-deoxybenzomorphans devoid of opiate activity with their dextrorotatory phenolic counterparts suggests role of sigma 2 receptors in motor function

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Neural substrates of latent inhibition: the switching model

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Disruption of latent inhibition by acute administration of low doses of amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Selective loss of cerebral cortical Sigma, but not PCP binding sites in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl)guanidine on non-dopaminergic midbrain neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900223-9

7 January 2021

10.1016/S0091-3057(00)00223-9

Identifiers

DOI

1 reference

25 February 2018

release_opd7hos27baqrpdqviytb4pp64

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/opd7hos27baqrpdqviytb4pp64

24 November 2022

mapped directly with Wikidata item

1 reference

25 February 2018